| SYRE | INST-CLUSTER | neutral | 3/10 | Four mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity) collectively added $468.9M in SY | Jun 11, 2026 |
| KLRS | INST-CLUSTER | neutral | 3/10 | Three mega-passive institutional investors (Vanguard, State Street, Morgan Stanley) increased their KLRS positions in Q3 | Jun 11, 2026 |
| XFOR | INST-CLUSTER | neutral | 3/10 | Five major institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) collectively added $84. | Jun 11, 2026 |
| AMLX | INST-CLUSTER | neutral | 3/10 | Four mega-passive institutional investors (BlackRock, State Street, Fidelity, Morgan Stanley) significantly increased th | Jun 11, 2026 |
| MBX | INST-CLUSTER | neutral | 3/10 | Three mega-passive institutional investors (Vanguard, BlackRock, Morgan Stanley) collectively added $40.7M to their MBX | Jun 11, 2026 |
| VSTM | INST-CLUSTER | neutral | 3/10 | Three mega-passive institutional investors (BlackRock, Fidelity, Morgan Stanley) collectively added $32.7M to their VSTM | Jun 11, 2026 |
| IMRX | INST-CLUSTER | neutral | 3/10 | Five mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) significantly in | Jun 11, 2026 |
| REX | INST-CLUSTER | neutral | 3/10 | Five mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) collectively add | Jun 11, 2026 |
| NKTR | INST-CLUSTER | neutral | 3/10 | Five mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) significantly in | Jun 11, 2026 |
| EVAX | 6-K | bullish | 6/10 | Evaxion announced new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, show | Jun 11, 2026 |
| BFRG | EFFECT | bearish | 5/10 | BullFrog AI Holdings' S-1 registration (File No. 333-296363) became effective on June 10, 2026, allowing Lincoln Park Ca | Jun 11, 2026 |
| FBRX | EFFECT | bearish | 6/10 | Forte Biosciences' universal shelf registration (File No. 333-296425) became effective on June 10, 2026, enabling the co | Jun 11, 2026 |
| TRIB | EFFECT | bearish | 6/10 | The SEC declared effective Trinity Biotech's F-1/A registration statement (File No. 333-293717), enabling the resale of | Jun 11, 2026 |
| STTK | 424B5 | bearish | 6/10 | Shattuck Labs is conducting a $75M underwritten public offering of 10.9M common shares and 7.9M pre-funded warrants at $ | Jun 11, 2026 |
| ALMS | INST-CLUSTER | neutral | 3/10 | Three mega-passive institutional investors (BlackRock, State Street, Fidelity) collectively added $162.0M in ALMS positi | Jun 11, 2026 |
| TNXP | INST-CLUSTER | neutral | 3/10 | Three mega-passive institutional investors, Vanguard, BlackRock, and Fidelity, all increased their positions in Tonix Ph | Jun 11, 2026 |
| RAPP | INST-CLUSTER | neutral | 3/10 | Three mega-passive institutional investors (Vanguard, BlackRock, Fidelity) collectively added $211.6M to their RAPP posi | Jun 11, 2026 |
| PVLA | INST-CLUSTER | neutral | 3/10 | Three mega-passive institutional investors (Vanguard, State Street, Fidelity) significantly increased their PVLA holding | Jun 11, 2026 |
| OCS | PRESS-RELEASE | neutral | 3/10 | Oculis announced a presentation at Clinical Trials at the Summit 2026 on its lead candidate Privosegtor, a peptoid small | Jun 11, 2026 |
| CLLS | PRESS-RELEASE | bullish | 7/10 | Cellectis presented final Phase 1 data for lasme-cel (CD22 allogeneic CAR-T) in r/r B-ALL at EHA 2026, showing 100% ORR | Jun 11, 2026 |
| EVAX | PRESS-RELEASE | neutral | 4/10 | Evaxion announced new preclinical data for its off-the-shelf AML vaccine EVX-04, demonstrating complete expression in hu | Jun 11, 2026 |
| ADTX | CLUSTER | bearish | 6/10 | Two 10% owners sold a combined ~$52K in ADTX stock over a 7-day window, with HRT Financial LP selling $46K and Gong Sand | Jun 10, 2026 |
| AXSM | CLUSTER | neutral | 4/10 | CEO Herriot Tabuteau and CFO Nick Pizzie sold a combined ~$19.9M in open-market sales on June 9, 2026, following derivat | Jun 10, 2026 |
| INM | CLUSTER | bullish | 7/10 | Two 10% owners (Vivo Opportunity, LLC and ADAR1 Capital Management, LLC) purchased a combined $189K of INM stock in an 8 | Jun 10, 2026 |
| HUMA | PRESS-RELEASE | bearish | 6/10 | Humacyte priced a $50M underwritten public offering of 47.6M shares at $1.05 per share, representing a roughly 20% disco | Jun 10, 2026 |
| ANIP | CLUSTER | neutral | 3/10 | CFO Stephen Carey exercised and sold option shares in a same-day cashless transaction on June 5, and a director sold a s | Jun 10, 2026 |
| HUMA | PRESS-RELEASE | bearish | 5/10 | Humacyte, Inc. has commenced an underwritten public offering of its common stock. The size and pricing of the offering h | Jun 10, 2026 |
| VIR | 3 | neutral | 1/10 | Timothy Coughlin filed a Form 3 initial statement of beneficial ownership with the SEC, reporting zero shares of Vir Bio | Jun 10, 2026 |
| ADTX | 8-K | bullish | 7/10 | Aditxt's wholly-owned subsidiary Ignite Proteomics signed a business combination agreement with SPAC Copley Acquisition | Jun 10, 2026 |
| ONC | CLUSTER | neutral | 2/10 | BeOne Medicines Ltd. (ONC) insiders executed a small cluster of open-market sales totaling $1.49M over eight days, led b | Jun 10, 2026 |